Synlogic Future Growth
Future criteria checks 0/6
Synlogic's revenue is forecast to decline at 171.4% per annum while its annual earnings are expected to grow at 76.2% per year. EPS is expected to grow by 120.7% per annum.
Key information
76.2%
Earnings growth rate
120.7%
EPS growth rate
Biotechs earnings growth | 24.0% |
Revenue growth rate | -171.4% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 23 Apr 2024 |
Recent future growth updates
Recent updates
Companies Like Synlogic (NASDAQ:SYBX) Could Be Quite Risky
Dec 28Can Synlogic (NASDAQ:SYBX) Afford To Invest In Growth?
Sep 12We're A Little Worried About Synlogic's (NASDAQ:SYBX) Cash Burn Rate
May 01Here's Why We're Watching Synlogic's (NASDAQ:SYBX) Cash Burn Situation
Nov 23Synlogic Therapeutics: SYNB1934 Advances To Phase 3
Oct 20Synlogic gets milestone payment under Roche pact to discover synthetic biotic for bowel disease
Sep 06Synlogic's metabolic disorder drug gets FDA fast track status
Aug 23Synlogic Q2 2022 Earnings Preview
Aug 10Is Synlogic (NASDAQ:SYBX) In A Good Position To Invest In Growth?
Aug 09Synlogic begins dosing in early-stage trial of SYNB1353 for rare metabolic disorder
Jul 12Here's Why We're Watching Synlogic's (NASDAQ:SYBX) Cash Burn Situation
Jan 11Companies Like Synlogic (NASDAQ:SYBX) Are In A Position To Invest In Growth
Sep 28Synlogic (SYBX) Investor Presentation - Slideshow
Jun 08Here's Why We Think Synlogic, Inc.'s (NASDAQ:SYBX) CEO Compensation Looks Fair
Jun 03Companies Like Synlogic (NASDAQ:SYBX) Are In A Position To Invest In Growth
Feb 23Synlogic (NASDAQ:SYBX) Share Prices Have Dropped 67% In The Last Three Years
Jan 19Synlogic outlines clinical milestones for 2021
Jan 11Our Take On Synlogic's (NASDAQ:SYBX) CEO Salary
Dec 15Synlogic, Inc. 2020 Q3 - Results - Earnings Call Presentation
Nov 08Synlogic EPS beats by $0.10
Nov 05Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | N/A | -11 | N/A | N/A | 1 |
12/31/2024 | N/A | -22 | N/A | N/A | 2 |
12/31/2023 | 3 | -57 | -52 | -52 | N/A |
9/30/2023 | 1 | -59 | -59 | -58 | N/A |
6/30/2023 | 1 | -65 | -61 | -61 | N/A |
3/31/2023 | 1 | -66 | -63 | -63 | N/A |
12/31/2022 | 1 | -66 | -58 | -57 | N/A |
9/30/2022 | 2 | -65 | -58 | -58 | N/A |
6/30/2022 | 2 | -63 | -57 | -56 | N/A |
3/31/2022 | 2 | -61 | -55 | -54 | N/A |
12/31/2021 | 2 | -61 | -53 | -52 | N/A |
9/30/2021 | 1 | -60 | -50 | -49 | N/A |
6/30/2021 | 0 | -57 | -44 | -43 | N/A |
3/31/2021 | 0 | -58 | -41 | -41 | N/A |
12/31/2020 | 1 | -59 | -40 | -40 | N/A |
9/30/2020 | 2 | -57 | -42 | -41 | N/A |
6/30/2020 | 2 | -57 | -44 | -43 | N/A |
3/31/2020 | 2 | -54 | -76 | -75 | N/A |
12/31/2019 | 2 | -51 | -77 | -75 | N/A |
9/30/2019 | 1 | -51 | -75 | -73 | N/A |
6/30/2019 | 3 | -48 | -76 | -72 | N/A |
3/31/2019 | 3 | -50 | -47 | -43 | N/A |
12/31/2018 | 3 | -48 | -48 | -42 | N/A |
9/30/2018 | 3 | -48 | -47 | -43 | N/A |
6/30/2018 | 1 | -49 | -45 | -40 | N/A |
3/31/2018 | 3 | -44 | -42 | -37 | N/A |
12/31/2017 | 2 | -40 | -34 | -31 | N/A |
9/30/2017 | 2 | -36 | N/A | -29 | N/A |
6/30/2017 | 2 | -29 | N/A | -26 | N/A |
3/31/2017 | 0 | -24 | N/A | -23 | N/A |
12/31/2016 | 0 | -21 | N/A | -20 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SYBX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: SYBX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: SYBX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: SYBX is forecast to have no revenue next year.
High Growth Revenue: SYBX is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SYBX's Return on Equity is forecast to be high in 3 years time